Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 10.99M P/E - EPS this Y 91.20% Ern Qtrly Grth -
Income -7.99M Forward P/E -0.35 EPS next Y -16.50% 50D Avg Chg -32.00%
Sales 55.88k PEG - EPS past 5Y - 200D Avg Chg -58.00%
Dividend N/A Price/Book 1.26 EPS next 5Y - 52W High Chg -92.00%
Recommedations 1.50 Quick Ratio 1.31 Shares Outstanding 650.31K 52W Low Chg 57.00%
Insider Own 5.44% ROA -96.93% Shares Float 558.22K Beta 0.99
Inst Own 13.59% ROE -264.57% Shares Shorted/Prior 4.34K/8.21K Price 0.33
Gross Margin - Profit Margin - Avg. Volume 3,966,956 Target Price 148.00
Oper. Margin -21,968.55% Earnings Date Dec 12 Volume 322,774 Change 1.26%
About Sonnet BioTherapeutics Holdings

Sonnet BioTherapeutics Holdings, Inc., a biotechnology company, owns a platform for biologic medicines of single or bifunctional action. The company develops fully human albumin binding technology, which utilizes human single chain antibodies fragment that binds to and hitch-hikes on human serum albumin for transport to target tissues. Its lead product candidate is SON-1010, a fully human single-chain version of interleukin 12 that is in Phase 1b/2a clinical trial for the treatment of solid tumor indications, including ovarian cancer, non-small cell lung cancer, and head and neck cancer. The company is also developing SON-080, a fully human version of interleukin 6, which is in Phase 1b/I2a clinical trail to treat chemotherapy-induced peripheral neuropathy and diabetic peripheral neuropathy; and SON-1210, a bispecific compound for solid tumor indications, including colorectal cancer. It has a license agreement with New Life Therapeutics Pte, LTD. to develop and commercialize pharmaceutical preparations containing a specific recombinant human interleukin-6; and strategic development collaboration with Sarcoma Oncology Center to advance SON-1210. The company is headquartered in Princeton, New Jersey.

Sonnet BioTherapeutics Holdings News
11/12/24 Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
11/06/24 Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
11/06/24 Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
10/17/24 Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
10/10/24 Sonnet BioTherapeutics’ Strategic Deal to Develop DPN Treatment
10/09/24 Sonnet BioTherapeutics Inc. Enters into Licensing Agreement with Alkem Laboratories Limited to Develop and Commercialize SON-080 for Diabetic Peripheral Neuropathy (DPN) in India
10/04/24 Sonnet BioTherapeutics to Receive Non-Dilutive Funding Through New Jersey Tax Certificate Transfer and Australia R&D Tax Incentive Programs
09/30/24 Sonnet BioTherapeutics Announces Launch of CEO Corner Platform
09/25/24 Sonnet BioTherapeutics Announces 1-for-8 Reverse Stock Split
09/18/24 Sonnet BioTherapeutics Completes Enrollment in Phase 1 Study of SON-1010 (IL12-FHAB) as a Monotherapy (SB101) for the Treatment of Solid Tumors
09/04/24 Sonnet BioTherapeutics to Participate in the Virtual Investor Closing Bell Series
08/19/24 Sonnet BioTherapeutics Enters into Clinical Collaboration Agreement to Commence Investigator-Initiated and Funded Phase 1/2a Study of SON-1210 in Combination with Chemotherapy for the Treatment of Pancreatic Cancer
08/14/24 Sonnet BioTherapeutics Reports Third Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update
07:30 AM Sonnet BioTherapeutics Reports Encouraging Data from Phase 1b/2a Clinical Trial of SON-080 in Chemotherapy-Induced Peripheral Neuropathy (CIPN) That Support Advancement into Phase 2 Study
06/20/24 Sonnet BioTherapeutics Announces Exercise of Warrants for $3.4 Million in Gross Proceeds
06/13/24 Sonnet BioTherapeutics Announces the Generation and Characterization of Two Novel Immunotherapeutic Pipeline Drug Candidates, SON-1411 and SON-1400, Each Containing a Variant IL-18 Domain
05/28/24 Sonnet BioTherapeutics to Present SB221 as a Trial in Progress at the ASCO 2024 Annual Meeting
05/22/24 Sonnet BioTherapeutics Announces Review of Strategic Alternatives
05/20/24 Sonnet BioTherapeutics Announces Updated Clinical Data for SON-1010 as Monotherapy or Combined with an anti-PD-L1, along with an Increase in the Dose-Escalation Target
05/14/24 Sonnet BioTherapeutics Provides Fiscal Year 2024 Second Quarter and Year-to-Date Business and Earnings Update
SONN Chatroom

User Image Stocksrockman Posted - 12 hours ago

$ABVE looking forward to Monday This is my top choice 🔥 $SNAX is bullish $ELF is going back up $SONN uptrend with $OBLG

User Image Pika_Capital Posted - 16 hours ago

@PLX_BULLS @campb029 lol stop your BS. $Atos, $HEPA, $sonn, $Opk. You were pumping them all

User Image Layla_Brooks_ Posted - 2 days ago

🚨 MYNZ Petra Brand Ambassador says to keep an eye on "BIG NEWS from the NFL." This is going to run parabolic soon, right after the healthcare giant Thermo Fisher ($210B mkt cap) partnered with Mainz to develop and launch together ColoAlert in US 🚀 Buy the dip now, the train is leaving very soon. $JFBR $SONN $LILM

User Image Beaviez Posted - 2 days ago

@WallStreetBuyDip when's the $SONN trade?

User Image WallStreetBuyDip Posted - 3 days ago

Here's the result for Small + Mid cap stocks. Do you see why I only buy when H% is low? Got timestamps + buy fills for everything. The result speaks for itself. $SPY Next will trade $SONN

User Image Jackie_Treehorn Posted - 3 days ago

$SONN

User Image Hallochen Posted - 4 days ago

$ADIL $QLGN $SONN $NDRA $SIDU It's getting slow. Soon to the Moon 🔥🚀🚀🚀

User Image IndicatorGator Posted - 5 days ago

Watchlist for 19 Nov 24: High volatility day trades. Take profits 5 to 20%. Not financial advice, opinion only. Hope everyone makes profits. $NCNC $SOAR $SONN $BKKT

User Image UnknownMan82 Posted - 5 days ago

$SONN last time when touching 12.50, all the way down to 5 halted, multiple times. not sure why they don't let it run.

User Image _www_larval_com_ Posted - 5 days ago

$QMMM 4%[-76%] $AGFY 4%[28%] $SONN 3%[-3%] $TRNR -3%[-10%] $WAVE 3%[42%] most notable movement into the final minutes of trading.

User Image Jackie_Treehorn Posted - 5 days ago

$SONN downward spiral never ends here!

User Image KillerTrader Posted - 5 days ago

$SONN stop loss hunters up From Now

User Image Russell007xx Posted - 5 days ago

$SONN halted? Why

User Image LuckyCs Posted - 5 days ago

$SONN what’s this sh**?!

User Image 1UpOnWallStreet Posted - 5 days ago

$SONN Damn, what a killer.

User Image HaltTradeAlert Posted - 5 days ago

$SONN Halt Time: 13:26:47 Issue Symbol: SONN Reason Code: LUDP Last Price: $2.77 Volume: 278.2 K Members get this halt alert with no delay and with more info: shares outstanding, market cap, relative volume, and percentage change on the day. Also, halt alerts for pre-market hours and after market hours which is extremely important for Code T1 News Pending Alerts!! And free real time news catalyst alerts!

User Image LuckyCs Posted - 5 days ago

$SONN rip it 🔥

User Image Beaviez Posted - 5 days ago

$SONN even this is up. God please 🥺 I need $9 to break even 🙏

User Image BigTimePennyStocks Posted - 6 days ago

Small-Caps Watchlist for this Week: ( $SONN, $VSEE, $CUTR, $GNS, $SNTI ) Free Article in Bio with Catalysts #NASDAQ #NYSE

User Image Sensei_What Posted - 1 week ago

Keeping my eyes on $NNE & $SONN. They got some folks with their dirty deeds, but their offerings have both been priced and they look to be setting up for further movement. I am heavy in $ZONE. Shorts have created a situation where it has the potential to squeeze well beyond the practicable share value. And they have plenty of cash and zero dilution in their filings.

User Image Stocksrockman Posted - 1 week ago

$ZONE moving up nicely, both in trend and hype $SONN bounce $PMEC something is happening $ABLV I have eyes here $WAFU will run soon

User Image Betty__Bustanut Posted - 1 week ago

$ZONE Hard watch on $NNE & $SONN. Their offerings have both been priced and they look to be setting up for further movement. I am heavy in $ZONE. It is sustaining its ER run well and has a lot of attention. Some of that sttention is coming from shorts, which in this case is a good thing because they are incompetent. They are maxed out, ineffective and trapped. This means it can squeeze well beyond the practicable value of the company. In addition to this they have plenty of cash and zero dilution in their filings. I'm holding green plus 17% right now but this is a hold for a big score and I won't sell before a first target of 50%.

User Image Bobby__Slapselrod Posted - 1 week ago

$LGMK $SONN $ZONE let’s push it to the limit! ZONE 52 week highs coming soon

User Image LordThanaton Posted - 1 week ago

$SONN $ZONE $NNE don't fall for these pumpers, they been accumulating for 2 days, stonk tanking they need to find suckers to unload on

User Image Betty__Bustanut Posted - 1 week ago

$ZONE Hard watch on $NNE & $SONN. Their offerings have both been priced and they look to be setting up for further movement. I am heavy in $ZONE. It is sustaining its ER run well and has a lot of attention. Some of that sttention is coming from shorts, which in this case is a good thing because they are incompetent. They are maxed out, ineffective and trapped. This means it can squeeze well beyond the practicable value of the company. In addition to this they have plenty of cash and zero dilution in their filings. I'm holding green plus 17% right now but this is a hold for a big score and I won't sell before a first target of 50%. .

User Image WallStreetBuyDip Posted - 1 week ago

Here's the result for Small + Mid cap stocks. Do you see why I only buy when H% is low? Got timestamps + buy fills for everything. The result speaks for itself. $SPY Next will trade $SONN

User Image Jennie_G Posted - 1 week ago

$ZONE Their books are clean as a whistle! That matters to me! When you look at stocks like $SONN and $ICCM that have pending S-1's, you naturally appreciate the stability of a stock like $ZONE running on good earnings. All in! .

User Image Jackie_Treehorn Posted - 1 week ago

$SONN when is next reverse split?

User Image Gratz34 Posted - 1 week ago

$SONN typical sonn fashion it seems, rs, random pump and then back to penny land

User Image Buysellbkr Posted - 1 week ago

$SONN ⚠️

Analyst Ratings
Chardan Capital Buy Aug 23, 24
Chardan Capital Buy May 28, 24
EF Hutton Buy May 16, 24
Chardan Capital Buy Feb 15, 24
Ladenburg Thalmann Buy Nov 27, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dyrness Albert D. Director Director May 30 Buy 0.468 23,255 10,883 28,962 05/31/23
Bhatt Nailesh Director Director May 17 Buy 0.232 25,000 5,800 30,733 05/18/23
Mohan Pankaj Chairman, President.. Chairman, President and CEO May 15 Buy 0.223 371,600 82,867 553,331 05/15/23